Liver Carcinoma

general

A carcinoma that arises from the hepatocytes or intrahepatic bile ducts. The main subtypes are hepatocellular carcinoma (hepatoma) and cholangiocarcinoma.

96

Centers

225

Active Trials

$5.7B

Cancer Funding

Specific Cancer Types(4)

Top Centers for Liver Carcinoma(96)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
71.5
2
NCI Comprehensive
High-Volume Research Center
71.5
3
NCI Comprehensive
High-Volume Research Center
71.5
4
NCI Comprehensive
High-Volume Research Center
71.5
5
NCI Clinical
High-Volume Research Center
71.5
6
Active Research Program
66.5
7
NCI Comprehensive
Active Research Program
49.0
8
NCI Comprehensive
Active Research Program
49.0
9
NCI Comprehensive
Active Research Program
49.0
10
NCI Comprehensive
Active Research Program
49.0
11
NCI Comprehensive
Active Research Program
49.0
12
NCI Comprehensive
Active Research Program
49.0
13
NCI Comprehensive
Active Research Program
49.0
14
NCI Comprehensive
Active Research Program
49.0
15
NCI Comprehensive
Active Research Program
49.0
16
NCI Comprehensive
Active Research Program
49.0
17
NCI Comprehensive
Active Research Program
49.0
18
NCI Comprehensive
Active Research Program
49.0
19
NCI Comprehensive
Active Research Program
49.0
20
NCI Comprehensive
Active Research Program
49.0
21
NCI Comprehensive
Active Research Program
49.0
22
NCI Comprehensive
Active Research Program
49.0
23
NCI Comprehensive
Active Research Program
49.0
24
NCI Comprehensive
Active Research Program
49.0
25
NCI Comprehensive
Active Research Program
49.0
2649.0
27
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
49.0
28
NCI Comprehensive
Active Research Program
49.0
29
NCI Comprehensive
Active Research Program
49.0
30
NCI Comprehensive
Active Research Program
49.0
31
NCI Comprehensive
Active Research Program
49.0
32
NCI Comprehensive
Active Research Program
49.0
33
NCI Comprehensive
Active Research Program
49.0
34
NCI Clinical
Active Research Program
49.0
35
NCI Comprehensive
Active Research Program
49.0
36
NCI Comprehensive
Active Research Program
49.0
37
NCI Comprehensive
Active Research Program
49.0
38
NCI Comprehensive
Active Research Program
49.0
39
NCI Clinical
Active Research Program
49.0
40
NCI Comprehensive
Active Research Program
49.0
41
Active Research Program
49.0
42
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
49.0
43
Active Research Program
49.0
44
Active Research Program
49.0
45
NCI Comprehensive
Active Research Program
49.0
46
NCI Comprehensive
Active Research Program
49.0
47
NCI Clinical
Active Research Program
49.0
48
NCI Comprehensive
Active Research Program
49.0
49
NCI Comprehensive
Active Research Program
49.0
50
NCI Comprehensive
Active Research Program
49.0
51
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
49.0
52
Active Research Program
49.0
53
NCI Comprehensive
Active Research Program
49.0
54
Active Research Program
49.0
55
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
49.0
56
Active Research Program
49.0
57
NCI Comprehensive
Active Research Program
49.0
5849.0
59
Active Research Program
49.0
60
Active Research Program
49.0
61
Active Research Program
49.0
62
NCI Basic_laboratory
Active Research Program
49.0
63
Active Research Program
49.0
64
Active Research Program
49.0
65
Active Research Program
49.0
66
Active Research Program
49.0
67
Active Research Program
49.0
68
Active Research Program
49.0
69
Active Research Program
49.0
70
Active Research Program
49.0
7149.0
72
Active Research Program
49.0
73
Active Research Program
49.0
74
Active Research Program
49.0
75
Active Research Program
49.0
76
Active Research Program
49.0
77
Active Research Program
49.0
78
79
80
81
NCI Comprehensive
82
NCI Comprehensive
83
84
85
NCI Comprehensive
86
87
88
NCI Clinical
89
90
NCI Comprehensive
91
92
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
93
94
95
BC CancerVancouver, BC
96

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →